Rx Vitamins CoQ1030 Coenzyme Q10 Capsules for Dogs & Cats, 30 Capsules
-
Secure payments
- In stock, ready to ship
Coenzyme Q10 (ubiquinol/ubiquinone) is a fat-soluble compound essential for mitochondrial energy production. Found in highest concentrations in tissues with the greatest energy demands — the heart, liver, and skeletal muscle — CoQ10 plays a dual role as both an electron carrier in the electron transport chain and as a powerful lipid-soluble antioxidant protecting mitochondrial membranes from oxidative damage.
In dogs and cats, CoQ10 supplementation is most commonly indicated for cardiovascular support (particularly in breeds prone to dilated cardiomyopathy or mitral valve disease), liver disease, and conditions involving significant mitochondrial oxidative stress. CoQ10 levels are also known to decline with age and with the use of certain medications — statin-type drugs and other mitochondrial suppressants — creating a supplementation gap in older patients or those on long-term medication.
Rx Vitamins CoQ1030 delivers 30 mg of CoQ10 per capsule in a formulation optimized for bioavailability. CoQ10 has notoriously poor oral absorption due to its hydrophobic nature and large molecular size; the CoQ1030 formulation uses an oil-based carrier to significantly improve absorption compared to dry powder formats. Each jar contains 30 capsules, providing a full month of once-daily support for average-sized pets.
Coenzyme Q10 (ubiquinone), 30 mg — essential cofactor in the mitochondrial electron transport chain; lipid-soluble antioxidant. Oil base carrier — significantly improves CoQ10 absorption over dry powder formulations.
Give one capsule daily with food, or as directed by your veterinarian. Capsules can be opened and the contents mixed into food if whole-capsule administration is not possible. Give with a meal containing fat to maximize absorption.
CoQ10 absorption is one of the most significant formulation challenges in nutraceuticals — standard dry powder capsules have absorption rates of 1–3%, making the stated dose largely irrelevant. An oil-suspended formulation like CoQ1030 achieves substantially higher bioavailability. For cardiac patients, the evidence supports CoQ10 as a useful adjunct to conventional therapy (pimobendan, ACE inhibitors), not a replacement. In dogs with DCM, CoQ10 is often started early in the disease course when the myocardium may be particularly responsive to energetic support.